Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 3/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26020408 | 0.97 | CYP1A1 (0.37) | CYP1A1CYP1B1CYP1A2GPR84S1PR4 | |
| SCHEMBL26020402 | 0.95 | CYP1A1 (0.38) | CYP1A1CYP1B1CYP1A2CYP11B1ALOX5 | |
| SCHEMBL26020503 | 0.95 | CYP1A1 (0.38) | CYP1A1CYP1B1CYP1A2CYP11B1ALOX5 | |
| SCHEMBL24825978 | 0.94 | CYP1A1 (0.40) | CYP1A1CYP1B1CYP1A2GPR84CYP11B1 | |
| SCHEMBL26020409 | 0.94 | CYP1A1 (0.40) | CYP1A1CYP1B1CYP1A2GPR84CYP11B1 | |
| SCHEMBL26021565 | 0.93 | CYP1A1 (0.37) | CYP1A1CYP1B1CYP1A2CYP11B1 | |
| SCHEMBL26021361 | 0.92 | CYP1A1 (0.35) | CYP1A1CYP1B1CYP1A2GPR84S1PR4 | |
| SCHEMBL26020413 | 0.92 | CYP1A1 (0.37) | CYP1A1CYP1B1CYP1A2CYP11B1 | |
| SCHEMBL26021462 | 0.92 | CYP1A1 (0.37) | CYP1A1CYP1B1CYP1A2ALOX5 | |
| SCHEMBL26021593 | 0.92 | CYP1A1 (0.37) | CYP1A1CYP1B1CYP1A2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242498-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, NR1D1 | CYP1A1 8/4885CYP1B1 43/4885CYP1A2 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.